It activates NF-κB and MAPK signaling pathways to suppress apoptosis, promote proliferation and survival, and induce EMT—mediated by transcription factors including Snail and ZEB1—thereby enhancing the migratory, invasive, and metastatic capacity of prostate cancer cells. Here, NFKB1 is linked to prostate cancer.